Literature DB >> 7457486

The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism.

R Cheely, W H McCartney, J R Perry, D J Delany, L Bustad, V H Wynia, T R Griggs.   

Abstract

We studied 243 patients in whom 248 pulmonary angiograms were performed because of suspected pulmonary embolism. Ventilation and perfusion lung scanning in 140 of them revealed 38 to be in low and high probability groups. Of 19 patients with subsegmental and nonsegmental perfusion defects that were matched with ventilation defects, none had pulmonary embolism. Conversely, angiography was positive in 17 of 19 patients with multiple segmental or lobar perfusion defects in areas of normal ventilation. Doppler flow examinations of the veins of the legs showed normal flow in 61 of 79 (77 percent) patients with pulmonary emboli and, therefore, were insensitive indicators of embolism. There was no mortality from angiography, and serious complications occurred in 2 percent of the patients. Anticoagulation in 83 patients was associated with bleeding in 25, two of whom died. The data indicate that ventilation-perfusion lung scanning can be used to separate many of the patients suspected of having pulmonary embolism who need anticoagulant treatment from those who do not. However, there is a considerable number of patients with nonspecific abnormalities on lung scan. For this group of patients with nonspecific abnormalities, the risk of complications from empiric treatment with anticoagulant drugs is probably greater than the risk of complications from pulmonary angiography. Further, our data show that patients with negative angiography have a very low risk of subsequent pulmonary embolism. In this group of patients, therefore, pulmonary embolism should be demonstrated by angiography before long-term anticoagulant therapy is prescribed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7457486     DOI: 10.1016/0002-9343(81)90406-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  British Thoracic Society guidelines for the management of suspected acute pulmonary embolism.

Authors: 
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

2.  Pulmonary embolism: is multislice CT the method of choice? For.

Authors:  Ieneke J C Hartmann; Mathias Prokop
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

3.  Overdiagnosis of pulmonary embolism: evaluation of a hypoxia algorithm designed to avoid this catastrophic problem.

Authors:  Brian S Winters; Mark Solarz; Christina L Jacovides; James J Purtill; Richard H Rothman; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

4.  Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism.

Authors:  J Lichey; I Reschofski; T Dissmann; M Priesnitz; M Hoffmann; H Lode
Journal:  Klin Wochenschr       Date:  1991-08-16

Review 5.  The value of lung scintigraphy in the diagnosis of pulmonary embolism.

Authors:  E J van Beek; M M Tiel-van Buul; H R Büller; E A van Royen; J W ten Cate
Journal:  Eur J Nucl Med       Date:  1993-02

6.  Diagnostic approach to pulmonary embolism: our strategy.

Authors:  A Vincent; S Poli; C Perret
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

7.  Scintigraphic evaluation of pulmonary embolism after total hip replacement, using a dry 99mTc-microaerosol for regional ventilation.

Authors:  H Fredin; M Arborelius
Journal:  Eur J Nucl Med       Date:  1982

8.  Pulmonary digital subtraction angiography.

Authors:  J Kollath; H Riemann
Journal:  Cardiovasc Intervent Radiol       Date:  1983       Impact factor: 2.740

9.  The diagnosis of pulmonary embolus.

Authors:  B Lo
Journal:  West J Med       Date:  1982-06

10.  Applicability of decision analysis to everyday clinical practice: a controlled feasibility trial.

Authors:  A Morabia; M Steinig-Stamm; P F Unger; D Slosman; P A Schneider; A Perrier; A F Junod
Journal:  J Gen Intern Med       Date:  1994-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.